Virginia Retirement Systems’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,300
Closed -$60.1K 967
2023
Q1
$60.1K Sell
13,300
-1,300
-9% -$9.85K ﹤0.01% 1016
2022
Q4
$165K Sell
14,600
-700
-5% -$7.86K ﹤0.01% 1072
2022
Q3
$146K Buy
+15,300
New +$178K ﹤0.01% 1090

Other funds holding ALXO

Virginia Retirement Systems's ALXO Position: Q2 2023 in Review

Virginia Retirement Systems sold out of ALX Oncology (ALXO) in Q2 2023, closing a stake of 13,300 shares — an estimated $60.1K sold.

Virginia Retirement Systems first reported a position in ALXO in Q3 2022 and held it in 3 quarters. The position peaked at $165K in Q4 2022. 75 funds tracked by Wall St. Rank hold ALXO as of Q2 2023.

  • Virginia Retirement Systems reported no remaining ALX Oncology position as of Q2 2023 after selling out during the quarter.
  • Virginia Retirement Systems sold 13,300 ALX Oncology shares in Q2 2023, an estimated $60.1K.
  • Virginia Retirement Systems first reported a position in ALX Oncology in Q3 2022 and held it in 3 quarters.
  • Virginia Retirement Systems's ALX Oncology position peaked at $165K in Q4 2022.
  • 75 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2023.

Based on Virginia Retirement Systems's 13F filing for Q2 2023, filed 22 Aug 2023.